Neel Shah

Dr. Neel Shah

Washington University School of Medicine St. Louis, MO, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2022 in Pediatric Research
Verified
Journal Article
Open access
PDF file
NSNeel Shah
Neel Shah
AAAhmed Arshad
Ahmed Arshad
MMMonty B. Mazer
Monty B. Mazer
CCChristopher L. Carroll
Christopher L. Carroll
SSSteven L. Shein
Steven L. Shein
KRKenneth E. Remy
Kenneth E. Remy
The field of pediatric critical care has been hampered in the era of precision medicine by our inability to accurately define and subclassify disease phenotypes. This has been caused by heterogeneity across age groups that further challenges the ability to perform randomized controlled trials in pediatrics. One approach to overcome these inherent challenges include the use of machine learning algorithms that can assist in generating more meaningful interpretations from clinical data. This review summarizes machine learning and artificial intelligence techniques that are currently in use for clinical data modeling with relevance to pediatric critical care. Focus has been placed on the differences between techniques and the role of each in the clinical arena. The various forms of clinical decision support that utilize machine learning are also described. We review the applications and limitations of machine learning techniques to empower clinicians to make informed decisions at the bedside. Impact Critical care units generate large amounts of under-utilized data that can be processed through artificial intelligence. This review summarizes the machine learning and artificial intelligence techniques currently being used to process clinical data. The review highlights the applications and limitations of these techniques within a clinical context to aid providers in making more informed decisions at the bedside.

15 July 2021 in Membranes
Verified
Journal Article
Open access
PDF file
NSNeel Shah
Neel Shah
@AhmedSaidICU Said@AhmedSaidICU Said
@AhmedSaidICU Said
Advances in extracorporeal membrane oxygenation (ECMO) technology are associated with expanded indications, increased utilization and improved outcome. There is growing interest in developing ECMO prognostication scores to aid in bedside decision making. To date, the majority of available scores have been limited to mostly registry-based data and with mortality as the main outcome of interest. There continues to be a gap in clinically applicable decision support tools to aid in the timing of ECMO cannulation to improve patients’ long-term outcomes. We present a brief review of the commonly available adult and pediatric ECMO prognostication tools, their limitations, and future directions.

22 August 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NSNeel Shah
Neel Shah
AFAbdelaziz Farhat
Abdelaziz Farhat
JTJefferson Tweed
Jefferson Tweed
ZWZiheng Wang
Ziheng Wang
JLJeon Lee
Jeon Lee
LRLakshmi Raman
Lakshmi Raman
Brain injury is a significant source of morbidity and mortality for pediatric patients treated with Extracorporeal Membrane Oxygenation (ECMO). Our objective was to utilize neural networks to predict radiographic evidence of brain injury in pediatric ECMO-supported patients and identify specific variables that can be explored for future research. Data from 174 ECMO-supported patients were collected up to 24 h prior to, and for the duration of, the ECMO course. Thirty-five variables were collected, including physiological data, markers of end-organ perfusion, acid-base homeostasis, vasoactive infusions, markers of coagulation, and ECMO-machine factors. The primary outcome was the presence of radiologic evidence of moderate to severe brain injury as established by brain CT or MRI. This information was analyzed by a neural network, and results were compared to a logistic regression model as well as clinician judgement. The neural network model was able to predict brain injury with an Area Under the Curve (AUC) of 0.76, 73% sensitivity, and 80% specificity. Logistic regression had 62% sensitivity and 61% specificity. Clinician judgment had 39% sensitivity and 69% specificity. Sequential feature group masking demonstrated a relatively greater contribution of physiological data and minor contribution of coagulation factors to the model's performance. These findings lay the foundation for further areas of research directions.

4 May 2023 in Artificial Organs
Verified
Journal Article
Closed access
NSNeel Shah
Neel Shah
BXBing Xue
Bing Xue
ZXZiqi Xu
Ziqi Xu
HYHanqing Yang
Hanqing Yang
EMEva Marwali
Eva Marwali
STSofia Tejada
Sofia Tejada

4 August 2023
Verified
Conference Paper
Open access
BXBing Xue
Bing Xue
@AhmedSaidICU Said@AhmedSaidICU Said
@AhmedSaidICU Said
ZXZiqi Xu
Ziqi Xu
HLHanyang Liu
Hanyang Liu
NSNeel Shah
Neel Shah
CLChenyang Lu
Chenyang Lu
Extracorporeal membrane oxygenation (ECMO) is an essential life-supporting modality for COVID-19 patients who are refractory to conventional therapies. However, the proper treatment decision has been the subject of significant debate and it remains controversial about who benefits from this scarcely available and technically complex treatment option. To support clinical decisions, it is a critical need to predict the treatment need and the potential treatment and no-treatment responses. Targeting this clinical challenge, we propose Treatment Variational AutoEncoder (TVAE), a novel approach for individualized treatment analysis. TVAE is specifically designed to address the modeling challenges like ECMO with strong treatment selection bias and scarce treatment cases. TVAE conceptualizes the treatment decision as a multi-scale problem. We model a patient's potential treatment assignment and the factual and counterfactual outcomes as part of their intrinsic characteristics that can be represented by a deep latent variable model. The factual and counterfactual prediction errors are alleviated via a reconstruction regularization scheme together with semi-supervision, and the selection bias and the scarcity of treatment cases are mitigated by the disentangled and distribution-matched latent space and the label-balancing generative strategy. We evaluate TVAE on two real-world COVID-19 datasets: an international dataset collected from 1651 hospitals across 63 countries, and a institutional dataset collected from 15 hospitals. The results show that TVAE outperforms state-of-the-art treatment effect models in predicting both the propensity scores and factual outcomes on heterogeneous COVID-19 datasets. Additional experiments also show TVAE outperforms the best existing models in individual treatment effect estimation on the synthesized IHDP benchmark dataset.

25 May 2026 in Critical Care Explorations
Verified
Journal Article
Open access
ADAdam C. Dziorny
Adam C. Dziorny
SDStephen Drury
Stephen Drury
ACAlex Clark
Alex Clark
RFReid W. D. Farris
Reid W. D. Farris
ANAkira Nishisaki
Akira Nishisaki
LSL. Nelson Sanchez-Pinto
L. Nelson Sanchez-Pinto
BACKGROUND: Acute kidney injury (AKI) is common in critically ill children and is associated with high morbidity and mortality. Risk prediction models designed for clinical decision support implementation can facilitate early identification and proactive mitigation of AKI risk. Existing models have primarily been validated using single-center data, partly because of the lack of appropriately detailed multicenter datasets. OBJECTIVE: To determine the performance of a single-center model to predict new AKI at 72 hours of ICU admission in children across two multicenter datasets and refine this model to improve prediction performance while maintaining acceptable alert burden. DERIVATION AND VALIDATION COHORTS: We analyzed two datasets: the Pediatric Learning Health System Network–Virtual Pediatric Systems (PEDSNET-VPS) dataset, created through the linkage of PEDSnet electronic health record (EHR) extraction with VPS (LLC, http://www.myvps.org), and the PICU Data Collaborative dataset, created through EHR extraction and harmonization from eight participating institutions. We divided each dataset into a derivation and test split. PREDICTION MODEL: We first recalibrated an existing single-center model and measured discrimination (area under the receiver operating characteristic curve [AUROC] and area under the precision-recall curve [AUPRC]) and performance at multiple cutpoints. We next added features available at 12 hours of ICU admission, optimizing by precision and recall. We measured discrimination and performance at multiple cutpoints and identified the features contributing most to the risk score. RESULTS: In total we analyzed 186,540 ICU admissions. We found early AKI by serum creatinine criteria within 72 hours of admission in 2.2–2.7%. Initial recalibration of an existing single-center model demonstrated poor discrimination (AUROC 0.65–0.78; AUPRC 0.10–0.12). Following the addition of new features, the model had higher AUROC (0.80–0.88) and AUPRC (0.13–0.22). CONCLUSIONS: In this first use of two new multicenter datasets, we found improved performance in a model designed using features available at 12 hours of ICU admission, balancing sensitivity and precision to predict patients at risk for AKI development.